Total Payments
$5,698
2024 Payments
$3,940
Companies
21
Transactions
106
Medicare Patients
147
Medicare Billing
$28,128
Payment Breakdown by Category
Food & Beverage$4,872 (85.5%)
Travel$787.85 (13.8%)
Other$38.69 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,872 | 103 | 85.5% |
| Travel and Lodging | $787.85 | 1 | 13.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38.69 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neuronetics, Inc. | $1,595 | 3 | $0 (2024) |
| Alkermes, Inc. | $918.90 | 12 | $0 (2024) |
| ITI, Inc. | $520.62 | 7 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $502.87 | 12 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $502.48 | 11 | $0 (2024) |
| Axsome Therapeutics, Inc. | $452.49 | 8 | $0 (2024) |
| Bausch Health US, LLC | $249.50 | 13 | $0 (2024) |
| ABBVIE INC. | $232.39 | 11 | $0 (2024) |
| Lundbeck LLC | $147.91 | 10 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $145.87 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,940 | 72 | Neuronetics, Inc. ($1,595) |
| 2023 | $981.17 | 25 | Alkermes, Inc. ($310.35) |
| 2022 | $350.55 | 3 | ITI, Inc. ($350.55) |
| 2021 | $121.20 | 1 | Neurocrine Biosciences, Inc. ($121.20) |
| 2020 | $122.63 | 1 | Otsuka America Pharmaceutical, Inc. ($122.63) |
| 2019 | $16.44 | 1 | Acorda Therapeutics, Inc ($16.44) |
| 2018 | $147.25 | 2 | Alkermes, Inc. ($125.00) |
| 2017 | $18.60 | 1 | Allergan Inc. ($18.60) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $33.08 | General |
| Category: Neuroscience | ||||||
| 11/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $787.85 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 11/15/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $746.71 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 11/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Neurology | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $112.70 | General |
| Category: CNS | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Neuropsychiatry | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/25/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: ANTI-ANXIETY | ||||||
| 09/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Neurology | ||||||
| 09/11/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Neurology | ||||||
| 09/10/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $125.46 | General |
| Category: SCHIZOPHRENIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 49 | 134 | $55,822 | $12,134 |
| 2022 | 1 | 11 | 31 | $12,917 | $2,743 |
| 2021 | 2 | 26 | 59 | $20,334 | $4,274 |
| 2020 | 3 | 61 | 96 | $37,499 | $8,976 |
Total Patients
147
Total Services
320
Medicare Billing
$28,128
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 97 | $40,418 | $8,334 | 20.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 15 | 15 | $8,474 | $2,274 | 26.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 22 | $6,930 | $1,525 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 31 | $12,917 | $2,743 | 21.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 11 | 34 | $9,917 | $2,186 | 22.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 15 | 25 | $10,417 | $2,089 | 20.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 30 | 30 | $15,599 | $3,639 | 23.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 38 | $14,452 | $3,582 | 24.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 28 | $7,448 | $1,756 | 23.6% |
About Dr. Hammad Mohsin, M.D
Dr. Hammad Mohsin, M.D is a Psychiatry healthcare provider based in Jamaica, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2010. The National Provider Identifier (NPI) number assigned to this provider is 1205167624.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hammad Mohsin, M.D has received a total of $5,698 in payments from pharmaceutical and medical device companies, with $3,940 received in 2024. These payments were reported across 106 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,872).
As a Medicare-enrolled provider, Mohsin has provided services to 147 Medicare beneficiaries, totaling 320 services with total Medicare billing of $28,128. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Jamaica, NY
- Active Since 01/25/2010
- Last Updated 06/28/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1205167624
Products in Payments
- NEUROSTAR TMS THERAPY SYSTEM (Device) $1,595
- CAPLYTA (Drug) $1,023
- Auvelity (Drug) $452.49
- ARISTADA (Drug) $441.30
- LYBALVI (Drug) $352.60
- ABILIFY ASIMTUFII (Drug) $299.73
- APLENZIN (Drug) $249.50
- VRAYLAR (Drug) $232.39
- REXULTI (Drug) $184.04
- INGREZZA (Drug) $145.87
- FANAPT (Drug) $125.46
- Aristada 441 mg (Drug) $125.00
- ABILIFY MYCITE (Drug) $122.63
- Azstarys (Drug) $52.05
- ABILIFY MAINTENA (Drug) $43.99
- UZEDY (Drug) $39.35
- JORNAY PM (Drug) $39.09
- SPRAVATO (Drug) $33.08
- BRIXADI (Drug) $23.73
- AMPYRA (Drug) $22.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Jamaica
Sanford Herman
Psychiatry — Payments: $832,093
Psychiatry $832,093
Zelimir Vukasin, Md, MD
Psychiatry — Payments: $79,529
Psychiatry $79,529
Aggy Vallanat, Md, MD
Psychiatry — Payments: $33,439
Psychiatry $33,439
Seeth Vivek, Md, MD
Psychiatry — Payments: $10,727
Psychiatry $10,727
Dr. Karamchand Rameshwar, M.d, M.D
Psychiatry — Payments: $3,091
Psychiatry $3,091
Dr. Xiaoling Song, M.d, M.D
Psychiatry — Payments: $2,635
Psychiatry $2,635